Blocking the interaction between circTNRC18 and LIN28A promotes trophoblast epithelial–mesenchymal transformation and alleviates preeclampsia
Molecular and Cellular Endocrinology · 2024
DOI: 10.1016/j.mce.2023.112073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024. Verfasst von Li-Li Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, PR China. Electronic address: zysjz123@sina.com. Hauptthemen laut MEDLINE: MicroRNAs, Pre-Eclampsia, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
Defects in migration and invasion caused by dysregulation of trophoblastic epithelial-mesenchymal transformation (EMT) play a vital role in preeclampsia (PE). We have previously shown that circTNRC18 inhibits the migration and EMT of trophoblasts; however, its role in PE remains unknown. Herein, we demonstrate that circTNRC18 interacts with an RNA-binding protein, lin-28 homolog A (LIN28A), and this interaction is enhanced in PE placental tissue. LIN28A overexpression suppresses circTNRC18-mediated inhibition of trophoblast migration, invasion, and EMT, whereas LIN28A knockdown promotes them. The intracellular distribution of LIN28A is regulated by circTNRC18, where it promotes the expression of insulin-like growth factor II by stabilizing its mRNA. circTNRC18 also promotes complex formation between GATA-binding factor 1 (GATA1) and sine oculis homeobox 1 (SIX1) by inhibiting LIN28A-GATA1 interaction. GATA1-SIX1 promotes transcription of grainyhead-like protein 2 homolog and circTNRC18-mediated regulation of cell migration and invasion. Moreover, blocking circTNRC18-LIN28A interaction with antisense nucleotides alleviates PE in a mouse model of reduced uterine perfusion pressure. Thus, targeting the circTNRC18-LIN28A regulatory axis may be a novel PE treatment method.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, PR China. Electronic address: zysjz123@sina.com.
- Department of Obstetrics, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, PR China. Electronic address: yaqinli1989@163.com.
- Department of Obstetrics, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, PR China. Electronic address: kangzhihui2013@163.com.
- Department of Obstetrics, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, PR China. Electronic address: zhangxuan1975@126.com.
- Department of Obstetrics, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, PR China. Electronic address: shizicaihong123@163.com.
- Department of Obstetrics, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, PR China. Electronic address: 109578218@qq.com.
Förderung
- Natural Science Foundation of Hebei Province
Zitieren
APA
Chen, L. L., Li, Y. Q., Kang, Z. H., Zhang, X., Gu, S. Y., Wang, N., & Shen, X. Y. (2024). Blocking the interaction between circTNRC18 and LIN28A promotes trophoblast epithelial–mesenchymal transformation and alleviates preeclampsia. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2023.112073
Vancouver
Chen LL, Li YQ, Kang ZH, Zhang X, Gu SY, Wang N, et al. Blocking the interaction between circTNRC18 and LIN28A promotes trophoblast epithelial–mesenchymal transformation and alleviates preeclampsia. Molecular and Cellular Endocrinology. 2024. doi:10.1016/j.mce.2023.112073
BibTeX
@article{Chen2024,
author = {Chen, Li-Li and Li, Ya-Qin and Kang, Zhi-Hui and Zhang, Xuan and Gu, Su-Yan and Wang, Na and Shen, Xue-Yan},
title = {Blocking the interaction between circTNRC18 and LIN28A promotes trophoblast epithelial–mesenchymal transformation and alleviates preeclampsia},
journal = {Molecular and Cellular Endocrinology},
year = {2024},
doi = {10.1016/j.mce.2023.112073}
}
EUVIMED